ECJ: potential competition exists between originators and generics
The European Court of Justice has held that competition can exist between a pharmaceutical patent-holder and generic drugmakers that are in a patent dispute.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.